Artemis Medicare Services Ltd
- Market Cap ₹ 5,096 Cr.
- Current Price ₹ 322
- High / Low ₹ 325 / 203
- Stock P/E 44.0
- Book Value ₹ 59.0
- Dividend Yield 0.14 %
- ROCE 14.6 %
- ROE 12.0 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 76.6% CAGR over last 5 years
Cons
- Stock is trading at 5.46 times its book value
- Company has a low return on equity of 12.2% over last 3 years.
- Promoter holding has decreased over last 3 years: -9.64%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 1000 BSE Hospitals BSE Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 547 | 565 | 408 | 555 | 737 | 879 | 937 | 1,081 | 1,114 | |
| 481 | 503 | 373 | 487 | 643 | 746 | 785 | 893 | 910 | |
| Operating Profit | 66 | 62 | 35 | 68 | 94 | 133 | 152 | 188 | 203 |
| OPM % | 12% | 11% | 9% | 12% | 13% | 15% | 16% | 17% | 18% |
| 2 | 4 | 7 | 3 | 7 | 7 | 33 | 27 | 25 | |
| Interest | 11 | 13 | 13 | 12 | 20 | 31 | 32 | 28 | 27 |
| Depreciation | 20 | 23 | 22 | 22 | 31 | 40 | 45 | 48 | 50 |
| Profit before tax | 37 | 31 | 8 | 37 | 51 | 68 | 108 | 139 | 152 |
| Tax % | 45% | 36% | 18% | 16% | 25% | 28% | 24% | 25% | |
| 20 | 19 | 6 | 31 | 38 | 49 | 82 | 104 | 114 | |
| EPS in Rs | 0.97 | 1.49 | 0.49 | 2.40 | 2.88 | 3.62 | 6.00 | 6.55 | 7.45 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 16% | 12% | 7% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 14% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 77% |
| 3 Years: | 41% |
| TTM: | 33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 55% |
| 3 Years: | 37% |
| 1 Year: | 29% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 12% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 16 |
| Reserves | 280 | 300 | 307 | 346 | 390 | 435 | 824 | 919 |
| 114 | 113 | 147 | 201 | 286 | 320 | 290 | 262 | |
| 147 | 160 | 133 | 149 | 216 | 203 | 229 | 232 | |
| Total Liabilities | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 | 1,429 |
| 381 | 393 | 383 | 489 | 605 | 719 | 745 | 804 | |
| CWIP | 49 | 56 | 81 | 64 | 95 | 33 | 40 | 29 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 124 | 137 | 136 | 157 | 205 | 219 | 572 | 596 | |
| Total Assets | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 | 1,429 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 40 | 56 | 27 | 60 | 127 | 109 | 156 | 132 | |
| -50 | -26 | -37 | -107 | -158 | -88 | -393 | -90 | |
| 14 | -27 | 18 | 44 | 38 | -29 | 264 | -50 | |
| Net Cash Flow | 5 | 2 | 8 | -3 | 7 | -8 | 27 | -8 |
| Free Cash Flow | -17 | 30 | -4 | -49 | -18 | 37 | 65 | 32 |
| CFO/OP | 76% | 98% | 83% | 63% | 138% | 94% | 112% | 79% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 49 | 49 | 48 | 46 | 39 | 39 | 40 |
| Inventory Days | ||||||||
| Days Payable | ||||||||
| Cash Conversion Cycle | 52 | 49 | 49 | 48 | 46 | 39 | 39 | 40 |
| Working Capital Days | -51 | -36 | -36 | -26 | -43 | -27 | -30 | -17 |
| ROCE % | 10% | 4% | 10% | 11% | 14% | 15% | 15% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ARPOB (Average Revenue Per Occupied Bed) - Gurgaon Hospital INR ・Standalone data |
|
|||||||||
| Bed Occupancy Rate - Gurgaon Hospital % ・Standalone data |
||||||||||
| ALOS (Average Length of Stay) - Gurgaon Hospital days ・Standalone data |
||||||||||
| Average Operational Census Beds - Gurgaon Hospital beds ・Standalone data |
||||||||||
| Surgeries Performed - Gurgaon Hospital count ・Standalone data |
||||||||||
| International Patient Revenue Share - Gurgaon Hospital % ・Standalone data |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Audio recording of Q1 FY27 earnings conference call made available on company website.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 1d
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
2d - CARE report for quarter ended June 30, 2026 shows no deviation; Rs 17.45 crore utilized from Rs 330 crore issue.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - Q1 FY27 results improved; Raipur hospital commenced operations in July 2026.
- Announcement under Regulation 30 (LODR)-Investor Presentation 2d
Annual reports
Concalls
-
Aug 2026TranscriptPPT REC
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022TranscriptAI SummaryPPT
Business Profile[1]
Promoted by Apollo Tyres Group, Artemis Medicare Services Ltd manages multi-specialty hospitals in Haryana under the brand Artemis Hospitals. The company provides a comprehensive range of advanced medical and surgical services across specialties such as cardiology, oncology, orthopedics, neurology, nephrology, gastroenterology, and critical care.